# Ex Vivo Expansion (ACT-X)

> **NCT07137312** · — · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 24 (estimated)

## Conditions studied

- Solid Tumor
- Healthy
- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Blood Draw
- **PROCEDURE:** Apheresis

## Key facts

- **NCT ID:** NCT07137312
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2028-10
- **Final completion:** 2028-10
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07137312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07137312, "Ex Vivo Expansion (ACT-X)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07137312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*